Back to Journals » Patient Preference and Adherence » Volume 13

Pilot Testing Of A Brief Pre-Consultation Screener For Improving The Identification And Discussion Of Medication Adherence In Routine Consultations

Authors Weinman J, Ali I, Hodgkinson A, Canfield M, Jackson C

Received 20 June 2019

Accepted for publication 3 October 2019

Published 5 November 2019 Volume 2019:13 Pages 1895—1898

DOI https://doi.org/10.2147/PPA.S219860

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Cristina Weinberg

Peer reviewer comments 3

Editor who approved publication: Dr Johnny Chen


John Weinman,1 Imran Ali,1 Anna Hodgkinson,2 Martha Canfield,3 Christina Jackson1

1Medicines Use Group, Institute of Pharmaceutical Sciences, Kings College London, London SE1 9NH, UK; 2NHS Lambeth Diabetes Team, Crown Dale Medical Centre, London SE19 3NY, UK; 3Health Psychology Section, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London SE1 9RT, UK

Correspondence: John Weinman
School of Cancer & Pharmaceutical Sciences, Kings College London, 5th Floor Franklin Wilkins Building, Stamford Street, London SE1 9NH, UK
Tel +44 207 848 4839
Email john.weinman@kcl.ac.uk

Objective: One of the challenges in being able to identify and manage medication adherence problems in routine practice is that patients are often reluctant to “admit to” non-adherence, particularly when asked in a direct way. The study reported in this paper has been designed as part of an attempt to address this problem by examining the value of a new brief medicines use screener in helping patients to identify and discuss adherence issues in a clinical setting.
Methods: 145 Patients with type 2 diabetes completed the new screener (MMWFU) together with an adherence self-report scale (MMAS4) and medication beliefs questionnaire (BMQ). Correlations between the scales were assessed together with an assessment of the sensitivity and specificity of the new screener.
Results: 126 (88%) of the sample identified at least one medicines-related issue on the MMWFU, which showed strong correlations with the MMAS4 and BMQ Concerns scales, as well as good sensitivity and specificity against the MMAS4.
Conclusion: The results indicate that the new screener can serve as a fairly sensitive indicator of non-adherence and its determinants. Future studies will be needed to establish how well it performs in other clinical settings.

Keywords: medication adherence, brief screener, medication beliefs, adherence assessment


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]